These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23077112)

  • 41. Static FET-PET and MR Imaging in Anaplastic Gliomas (WHO III).
    Bette S; Peschke P; Kaesmacher J; Delbridge C; Pyka T; Schmidt-Graf F; Zimmer C; Meyer B; Ringel F; Gempt J
    World Neurosurg; 2016 Jul; 91():524-531.e1. PubMed ID: 26947726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (18)F-Fluorothymidine PET-CT for resected malignant gliomas before radiotherapy: tumor extent according to proliferative activity compared with MRI.
    Zhao F; Li M; Wang Z; Fu Z; Cui Y; Chen Z; Yu J
    PLoS One; 2015; 10(3):e0118769. PubMed ID: 25738617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
    Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
    Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3'-Deoxy-3'-[(18)F]-fluorothymidine ([(18)F]-FLT) transport in newly diagnosed glioma: correlation with nucleoside transporter expression, vascularization, and blood-brain barrier permeability.
    Shinomiya A; Miyake K; Okada M; Nakamura T; Kawai N; Kushida Y; Haba R; Kudomi N; Tokuda M; Tamiya T
    Brain Tumor Pathol; 2013 Oct; 30(4):215-23. PubMed ID: 23423309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.
    Kobayashi K; Hirata K; Yamaguchi S; Manabe O; Terasaka S; Kobayashi H; Shiga T; Hattori N; Tanaka S; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1071-80. PubMed ID: 25852010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
    Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S
    Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rate of change in maximum
    Oughourlian TC; Yao J; Schlossman J; Raymond C; Ji M; Tatekawa H; Salamon N; Pope WB; Czernin J; Nghiemphu PL; Lai A; Cloughesy TF; Ellingson BM
    J Neurooncol; 2020 Mar; 147(1):135-145. PubMed ID: 31981013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.
    Eckel F; Herrmann K; Schmidt S; Hillerer C; Wieder HA; Krause BJ; Schuster T; Langer R; Wester HJ; Schmid RM; Schwaiger M; Buck AK
    J Nucl Med; 2009 Sep; 50(9):1441-7. PubMed ID: 19690030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.
    Collet S; Valable S; Constans JM; Lechapt-Zalcman E; Roussel S; Delcroix N; Abbas A; Ibazizene M; Bernaudin M; Barré L; Derlon JM; Guillamo JS
    Neuroimage Clin; 2015; 8():448-54. PubMed ID: 26106569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The roles of
    Kim S; Kim D; Kim SH; Park MA; Chang JH; Yun M
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1012-1020. PubMed ID: 29511838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.
    Gempt J; Bette S; Ryang YM; Buchmann N; Peschke P; Pyka T; Wester HJ; Förster S; Meyer B; Ringel F
    Eur J Radiol; 2015 May; 84(5):955-62. PubMed ID: 25748815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment.
    Herrmann K; Buck AK; Schuster T; Junger A; Wieder HA; Graf N; Ringshausen I; Rudelius M; Wester HJ; Schwaiger M; Keller U; Dechow T
    J Nucl Med; 2011 May; 52(5):690-6. PubMed ID: 21498532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy.
    Calcagni ML; Galli G; Giordano A; Taralli S; Anile C; Niesen A; Baum RP
    Clin Nucl Med; 2011 Oct; 36(10):841-7. PubMed ID: 21892031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
    Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
    Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [
    Guglielmo P; Quartuccio N; Rossetti V; Celli M; Alongi P; Boero M; Arnone G; Baldari S; Matteucci F; Laudicella R
    Curr Med Imaging; 2022; 18(4):363-371. PubMed ID: 34533446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.
    Morana G; Piccardo A; Tortora D; Puntoni M; Severino M; Nozza P; Ravegnani M; Consales A; Mascelli S; Raso A; Cabria M; Verrico A; Milanaccio C; Rossi A
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2084-2093. PubMed ID: 28752225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic usefulness of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography in recurrent brain tumor.
    Hong IK; Kim JH; Ra YS; Kwon DH; Oh SJ; Kim JS
    J Comput Assist Tomogr; 2011; 35(6):679-84. PubMed ID: 22082535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of 11F-fluorothymidine positron emission tomography in brain tumor].
    Kawai N; Kagawa M; Miyake K; Nishiyama Y; Yamamoto Y; Shiraishi H; Ichikawa T; Tamiya T
    No Shinkei Geka; 2009 Jul; 37(7):657-64. PubMed ID: 19621774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.